Skip to content

NERV - Minerva Neurosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Minerva Neurosciences Inc

NERV · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NERVMinerva Neurosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $8.80
52-wk low: $1.93
Prev close: $5.54
Mkt cap: $228.7M
Fwd P/E: 11.2x
Beta: -0.11

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$56.5M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$23.6M
position
FC
Farallon Capital
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in $0.45 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 11.21
Market cap: $229M

Valuation

P/S1.87
P/B2.68

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NERV
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $228.71M
Beta: -0.11

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

1.9x

P/B

2.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-675.0%

$13.1M

position

MI

Millennium

Israel Englander · Q2 2026 13F

$3.0M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NERV

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.46-$0.45

-$0.01 expected

Next report

What the street expects next

EPS expected

-$0.18

-$0.22 to -$0.14

Revenue expected

$0.00

3 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.05

Change in 30 days

-675.0%

ROA-35.0%

Growth

Beta-0.11